How deadly is Covid 19?

Episode Summary

Executive Summary: The episode explains why COVID-19 'death rate' claims can be misleading, distinguishing crude mortality rate, case fatality rate, and infection fatality rate. It shows how age structure, undercounted infections, and changing treatment affect risk estimates, then corrects a prior flu-statistics error and clarifies how 100,000 U.S. flu deaths were counted across the 1968 pandemic period, not a single year.

Main Topics: Why 'death rate' is an imprecise phrase (Priority: 5/5): The host distinguishes crude mortality rate, case fatality rate, and infection fatality rate, showing that different definitions produce very different interpretations of how deadly a disease is. Why case fatality rates can mislead during COVID-19 (Priority: 5/5): Confirmed cases miss many infections, especially early in the pandemic, so deaths divided by detected cases can exaggerate lethality compared with the true infection fatality rate. Age as the main driver of COVID-19 mortality risk (Priority: 5/5): Expert commentary emphasizes that fatality risk rises steeply with age, making population-wide averages poor proxies for individual risk or for comparisons across countries. Country-level differences in infection fatality rate (Priority: 4/5): Because countries have different age profiles, lower-income countries with younger populations have lower population-wide IFRs than higher-income countries with older populations. Local outbreaks and skewed case patterns (Priority: 4/5): The England university outbreak shows how a large spike in young cases can produce many infections but relatively few deaths, highlighting the mismatch between cases and mortality. Correcting the flu-deaths statistic (Priority: 4/5): The program revisits an earlier error about U.S. flu deaths, clarifying that the 100,000 figure referred to the 1968 Hong Kong flu pandemic over multiple years, not one year alone. Better treatment has reduced COVID fatality risk (Priority: 3/5): The episode notes that improved understanding and treatment have likely lowered the likelihood of dying from COVID-19 compared with early-pandemic estimates.

Key Arguments: 'Death rate' is not a single metric; crude mortality rate, case fatality rate, and infection fatality rate answer different questions. Case fatality rate can overstate danger because confirmed cases undercount total infections, especially when testing is limited. Infection fatality rate is more useful than case fatality rate for estimating true disease lethality, but it still varies by age and population structure. Older people face dramatically higher mortality risk from COVID-19 than younger people, so a single average IFR is misleading. Cross-country comparisons of IFR must account for demographic differences; younger countries will generally have lower population-wide IFRs. Localized outbreaks can drive case surges without proportional death surges when infections are concentrated among younger people. COVID-19 fatality risk appears to have fallen over time because of better treatment, better understanding, and improved management of the disease. The prior flu statistic was corrected: the 100,000 U.S. flu deaths figure referred to the broader 1968 pandemic period, not one calendar year.

Data Points: Time since pandemic began: over eight months - Opening framing for revisiting COVID-19 mortality rates Infection fatality rate, age 40s: 0.15% - Dr Hannah Ritchie’s example of COVID mortality risk for people in their 40s Infection fatality rate, over 80s: almost 1 in 10 (about 10%) - Dr Hannah Ritchie’s estimate for people over 80 who catch COVID-19 Expected deaths among 600 infected in their 40s: 1 death - Illustration of the 0.15% IFR for people in their 40s Expected deaths among 600 infected in their 80s: 60 deaths - Illustration of the much higher IFR for older adults Population-wide IFR in lower-income countries: around 0.23% - Imperial College London estimate cited for younger-country demographics Population-wide IFR in higher-income countries: around 1.15% - Imperial College London estimate cited for older-country demographics University cases in England spike: over 1,000 cases at some universities - Dr Daniel Howden describing the late-September student outbreak Cases among people under 30 in England since July 10: over 100,000 cases - Used to illustrate low mortality relative to case volume among younger people Deaths among people under 30 in England since July 10: 2 deaths - Shows how few deaths followed the large number of young infections COVID fatality risk reduction: 20% to 30% lower - Best estimate cited for reduced likelihood of death compared with early-pandemic levels U.S. flu deaths figure discussed: 100,000 - The disputed statistic referenced in relation to seasonal flu and the 1968 pandemic Period over which those flu deaths occurred: 1968 to 1972 - Clarification that the 100,000 deaths were spread across several years during the H3N2 pandemic Spanish flu second-wave U.S. deaths estimate: 195,000 - CDC belief cited for deaths in 1918, with uncertainty noted by other experts

Pivotal Quotes: "The case fatality rate is easy to calculate. Just divide one easily accessible number by another, but it can be quite misleading." — Tim Harford: Explaining why confirmed-case-based death rates can distort the true danger of a disease "The infection fatality rate, or the mortality risk, is very dependent on the age." — Dr Hannah Ritchie: Describing why COVID risk varies sharply by age group and cannot be summarized by one universal number "We have learned to live with it, just like we're learning to live with COVID, in most populations, far less lethal." — Tim Harford quoting Donald Trump: Introducing the later correction about the seasonal flu statistic and its misuse

Implications: Listeners should be cautious when hearing 'death rate' claims: the metric may be wrong for the question being asked. COVID risk is highly age-dependent, and better treatment plus demographic context matter greatly for interpretation.